Trial offers hope for vaccine against hepatitis C

A COUSIN of the common cold virus offers the first hope of an effective vaccine against the chronic liver infection hepatitis C, it has been revealed.

Early trial results mirror responses seen in the minority of people with natural immunity to the disease, which can lead to severe liver damage and early death.

Scientists are encouraged by the findings but last night cautioned it may take several more years to develop a fully approved vaccine.